Patient Case Studies
In the News
Apabetalone Reduces Risk of Major Cardiovascular Events After Recent ACS in Patients With Diabetes, Kidney Disease
By Chris Berrie CEPAGATTI, Italy -- June 16, 2020 -- Apabetalone reduces the risk of major adverse cardiovascular events (MACE) by 50% versus placebo in patients with type 2 diabetes, recent acute coronary syndrome (ACS), and chronic kidney disease (CKD), according to a study presented at the 2020...
By Alex Morrisson WEST PALM BEACH, Fla -- May 4, 2020 -- A low-field MRI scanner is feasible for use at the bedside of patients exhibiting symptoms of stroke, according to a study presented at the 2020 Virtual Meeting of the American Academy of Neurology (AAN). Kevin Sheth, MD, Yale School of...
By Alex Morrisson LOS ANGELES -- February 25, 2020 -- Patients undergoing carotid artery stenting to prevent recurrence of stroke who receive cilostazol tend to have a lower incidence of in-stent restenosis after 2 years, according to a study presented here at the 2020 International Stroke...
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- In patients with a history of stroke or transient ischaemic attacks, reducing low density lipoprotein (LDL) cholesterol to a goal of 70 mg/dL significantly reduces the risk of subsequent cardiovascular events, according to a study presented...
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- Patients with stroke who are identified as having intracerebral haemorrhage (ICH) may be helped by treatment with tranexamic acid, according to a study presented here at the 2020 International Stroke Conference (ISC). While there were...
American Journal of Emergency Medicine